Holen Sie sich die Stockscreener-App
1.08
0.93%
0.01
Handel nachbörslich:
1.02
-0.06
-5.56%
Schlusskurs vom Vortag:
$1.07
Offen:
$1.08
24-Stunden-Volumen:
22,472
Relative Volume:
0.29
Marktkapitalisierung:
$7.37M
Einnahmen:
Nettoeinkommen (Verlust:
$-19.54M
KGV:
-0.8263
EPS:
-1.3071
Netto-Cashflow:
$-21.18M
1W Leistung:
-16.92%
1M Leistung:
-45.45%
6M Leistung:
-65.99%
1J Leistung:
-93.12%
1-Tages-Spanne:
$1.05
$1.152
1-Wochen-Bereich:
$1.03
$1.275
52-Wochen-Spanne:
$1.03
$36.00
Calcimedica Inc Stock (CALC) Company Profile
Firmenname
Calcimedica Inc
Sektor
Branche
Telefon
858-952-5500
Adresse
505 COAST BOULEVARD SOUTH, LA JOLLA
Compare CALC vs VRTX, MRNA, REGN, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CALC
Calcimedica Inc
|
1.08 | 7.37M | 0 | -19.54M | -21.18M | -1.3071 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Calcimedica Inc Stock (CALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-08-20 | Eingeleitet | Guggenheim | Buy |
| 2026-01-29 | Herabstufung | H.C. Wainwright | Buy → Neutral |
Calcimedica Inc Aktie (CALC) Neueste Nachrichten
20,000 director stock options carry a $1.64 exercise price at CalciMedica (CALC). - Stock Titan
Stock sales may occur from time to time for CalciMedica (CALC) through H.C. Wainwright. - Stock Titan
CalciMedica CEO Rachel A. Leheny Awarded 360,000 Stock Options with Four-Year Vesting - Kalkine Media
At $1.74 a share, CalciMedica (CALC) gives its science chief options to buy 180,000 shares. - Stock Titan
Nasdaq $1 listing bar cleared by CalciMedica (NASDAQ: CALC) after earlier deficiency notice - Stock Titan
Investors can meet CalciMedica on Sept. 15 - Stock Titan
CalciMedica, Inc. (CALC) Stock Price & News - Syfe
CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk - The Globe and Mail
CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk - TipRanks
CalciMedica (NASDAQ: CALC) fixes one Nasdaq warning but faces a $1 price deadline - stocktitan.net
Stonepine Capital Management Expands CalciMedica Stake in Bold Contrarian Move - GuruFocus
CALC Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 7.84%Tax Rate Impact - vinanet.vn
CalciMedica Inc (CALC) Fundamental & Financial Data - Stocktwits
CalciMedica Announces One-for-Five Reverse Stock Split - The Globe and Mail
CalciMedica To Carry Out 1-for-5 Reverse Stock Split On August 31st, 2026 - Moomoo
CalciMedica executes 1-for-5 reverse stock split By Investing.com - Investing.com South Africa
CalciMedica executes 1-for-5 reverse stock split - Investing.com
CalciMedica executes 1-for-5 reverse stock split By Investing.com - Investing.com India
CalciMedica Announces One-for-Five Reverse Stock Split - The Manila Times
CalciMedica (CALC) Quarter in Focus: The Available Earnings Metric Delivers a Beat; Closing Move: Shares Move Higher 5.68% for the Current SessionROA Comparison - dars.gov.et
CalciMedica (CALC) Quarter in Focus: The Available Earnings Metric Delivers a Beat; Closing Move: Shares Move Higher 5.68% for the Current SessionEarnings Call Transcript - vinanet.vn
Stonepine takes CalciMedica (CALC) stake via capped warrants - Stock Titan
Alafi Capital updates CalciMedica (NASDAQ: CALC) stake after multimillion-warrant grant - stocktitan.net
CalciMedica (CALC) grants director 10,000 stock options through 2036 - Stock Titan
CalciMedica (NASDAQ: CALC) awards director 10,000 options at $0.61 - Stock Titan
CalciMedica (CALC) grants director 10,000 stock options at $0.61 - Stock Titan
CalciMedica (CALC) director granted 2.9M-share warrants with 9.99% cap - Stock Titan
CalciMedica (NASDAQ: CALC) grants FDA-linked warrants capped at 19.99% stake - Stock Titan
CalciMedica (NASDAQ: CALC) CEO granted new stock warrants - Stock Titan
CalciMedica (NASDAQ: CALC) has 9.99% holder blocked from using more warrants - Stock Titan
CalciMedica (CALC) Financial Update: EPS Lands Above Forecast in the Current Update; The Stock Ends Down 4.88% in the Current UpdateProfit Inflection Point - vinanet.vn
ARMISTICE CAPITAL, LLC Acquires Significant Stake in CalciMedica Inc (CALC) - GuruFocus
CalciMedica Shareholders Approve Reverse Stock Split - Minichart
CalciMedica Shareholders Approve Key Equity and Governance Changes - TipRanks
CalciMedica (NASDAQ: CALC) holders back reverse split and warrant deals - Stock Titan
Guggenheim initiates CalciMedica stock with buy rating on drug potential - Investing.com
Guggenheim initiates CalciMedica stock coverage with buy rating - Investing.com India
Guggenheim initiates CalciMedica stock with buy rating on drug potential - Investing.com
CalciMedica (CALC) Edges Higher by 2.71% as Shares Consolidate Between $0.65 and $0.71TRIN Signal - dars.gov.et
CalciMedica (CALC) Edges Higher by 2.71% as Shares Consolidate Between $0.65 and $0.71Overnight Profile - vinanet.vn
Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power - Stock Titan
Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica - Stock Titan
CALC Q1 2026 Earnings: EPS of $0.30 Crushes Estimates, Stock Advances 6%Revenue Miss Report - vinanet.vn
CALC Q1 2026 Earnings: EPS Swings to Profit With 205.04% SurpriseEarnings Sentiment Score - vinanet.vn
CalciMedica shares see H.C. Wainwright neutral rating reiterated - Investing.com
CalciMedica shares see H.C. Wainwright neutral rating reiterated By Investing.com - Investing.com Canada
Price to book forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView
CalciMedica shares see H.C. Wainwright neutral rating reiterated By Investing.com - Investing.com India
CalciMedica shares see H.C. Wainwright neutral rating reiterated By Investing.com - Investing.com UK
CalciMedica shares see H.C. Wainwright neutral rating reiterated - Investing.com
Finanzdaten der Calcimedica Inc-Aktie (CALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):